Provided is a curable composition that has a sufficient pot life and does not cause a significant delay in curing time even after long-term storage at room temperature or higher. A separately packed curable composition includes: (A) a first pack containing: (a1) a polymerizable monomer having no acidic group, (b) a polymerizable monomer having an acidic group, and (c) a transition metal compound; and (B) a second pack containing: (a2) a polymerizable monomer having no acidic group, (d) an aromatic amine compound, and (e) at least one compound selected from sulfinic acid and a salt thereof.

Provided is a curable composition that has a sufficient pot life and does not cause a significant delay in curing time even after long-term storage at room temperature or higher. A separately packed curable composition includes: (A) a first pack containing: (a1) a polymerizable monomer having no acidic group, (b) a polymerizable monomer having an acidic group, and (c) a transition metal compound; and (B) a second pack containing: (a2) a polymerizable monomer having no acidic group, (d) an aromatic amine compound, and (e) at least one compound selected from sulfinic acid and a salt thereof.

Disclosed is a medical filler composition, which is loaded in a space which is empty due to the removal of nerves, blood vessels, cell tissues and hard tissues therefrom and which is also biocompatible, highly bioactive and biochemically stable and has high workability and sealing ability, including a calcium supply source including at least one selected from among calcium hydroxide and calcium oxide, a silicon supply source including at least one selected from fumed silica, precipitated silica, colloidal silica and clay mineral, and 20 to 70 parts by weight of a liquid material for pasting, based on 100 parts by weight of a mixture of the calcium supply source and the silicon supply source, wherein the calcium/silicon molar ratio of calcium silicate hydrate produced by a pozzolanic reaction between the calcium supply source and the silicon supply source is 0.25 to 1.5.

Disclosed is a medical filler composition, which is loaded in a space which is empty due to the removal of nerves, blood vessels, cell tissues and hard tissues therefrom and which is also biocompatible, highly bioactive and biochemically stable and has high workability and sealing ability, including a calcium supply source including at least one selected from among calcium hydroxide and calcium oxide, a silicon supply source including at least one selected from fumed silica, precipitated silica, colloidal silica and clay mineral, and 20 to 70 parts by weight of a liquid material for pasting, based on 100 parts by weight of a mixture of the calcium supply source and the silicon supply source, wherein the calcium/silicon molar ratio of calcium silicate hydrate produced by a pozzolanic reaction between the calcium supply source and the silicon supply source is 0.25 to 1.5.

A curable mixture and method of using the mixture are disclosed. In some embodiments, the mixture comprises an alginate polymer, and comprises properties suitable for use as a tooth filling after curing.

A curable mixture and method of using the mixture are disclosed. In some embodiments, the mixture comprises an alginate polymer, and comprises properties suitable for use as a tooth filling after curing.

A composite material in one of embodiments includes a crystal phase of titanium fluoride and a metal crystal phase of titanium. The crystal phase of the titanium fluoride is present in a first region located away from a surface in a depth direction.

A composite material in one of embodiments includes a crystal phase of titanium fluoride and a metal crystal phase of titanium. The crystal phase of the titanium fluoride is present in a first region located away from a surface in a depth direction.

A biomimetic composite material includes a bioactive cement material, an autologous dentin matrix, and an inorganic nano-reinforcement material. A dental implant includes a body including a biomimetic composite material, wherein the biomimetic composite material includes a bioactive cement material, an autologous dentin matrix, and an inorganic nano-reinforcement material.

Object

Provided is a medical implant having favorable biocompatibility.

Solution to Problem

An implant used for binding to a biological tissue including bone or teeth, and made of metal selected from titanium or titanium alloys, cobalt chrome alloys, and tantalum, includes a surface layer portion of a portion, which is bound to a biological tissue including bone or teeth, of the implant, the surface layer portion having a porous structure. The porous structure includes a trunk hole formed in a thickness direction and including an opening on a binding face side, open holes each constituted of a branch hole formed extending from an inner wall surface of the trunk hole in a direction different from that of the trunk hole, an interior space formed in the thickness direction and not including an opening on the binding face side, a tunnel connecting path connecting the open holes and the interior space, and a tunnel connecting path connecting the open holes.